Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Bioactive Thymosin Alpha-1 Does Not Influence F508del-CFTR Maturation and Activity.

Armirotti A, Tomati V, Matthes E, Veit G, Cholon DM, Phuan PW, Braccia C, Guidone D, Gentzsch M, Lukacs GL, Verkman AS, Galietta LJV, Hanrahan JW, Pedemonte N.

Sci Rep. 2019 Jul 16;9(1):10310. doi: 10.1038/s41598-019-46639-1.

2.

Molecular autopsy and family screening in a young case of sudden cardiac death reveals an unusually severe case of FHL1 related hypertrophic cardiomyopathy.

Gaertner-Rommel A, Tiesmeier J, Jakob T, Strickmann B, Veit G, Bachmann-Mennenga B, Paluszkiewicz L, Klingel K, Schulz U, Laser KT, Karger B, Pfeiffer H, Milting H.

Mol Genet Genomic Med. 2019 Aug;7(8):e841. doi: 10.1002/mgg3.841. Epub 2019 Jul 10.

3.

Transcytosis maintains CFTR apical polarity in the face of constitutive and mutation-induced basolateral missorting.

Bidaud-Meynard A, Bossard F, Schnúr A, Fukuda R, Veit G, Xu H, Lukacs GL.

J Cell Sci. 2019 May 15;132(10). pii: jcs226886. doi: 10.1242/jcs.226886.

PMID:
30975917
4.

Structure-guided combination therapy to potently improve the function of mutant CFTRs.

Veit G, Xu H, Dreano E, Avramescu RG, Bagdany M, Beitel LK, Roldan A, Hancock MA, Lay C, Li W, Morin K, Gao S, Mak PA, Ainscow E, Orth AP, McNamara P, Edelman A, Frenkiel S, Matouk E, Sermet-Gaudelus I, Barnes WG, Lukacs GL.

Nat Med. 2018 Nov;24(11):1732-1742. doi: 10.1038/s41591-018-0200-x. Epub 2018 Oct 8.

5.

ΔF508-CFTR Modulator Screen Based on Cell Surface Targeting of a Chimeric Nucleotide Binding Domain 1 Reporter.

Phuan PW, Veit G, Tan JA, Roldan A, Finkbeiner WE, Haggie PM, Lukacs GL, Verkman AS.

SLAS Discov. 2018 Sep;23(8):823-831. doi: 10.1177/2472555218763310. Epub 2018 Mar 13.

6.

Chaperone-Independent Peripheral Quality Control of CFTR by RFFL E3 Ligase.

Okiyoneda T, Veit G, Sakai R, Aki M, Fujihara T, Higashi M, Susuki-Miyata S, Miyata M, Fukuda N, Yoshida A, Xu H, Apaja PM, Lukacs GL.

Dev Cell. 2018 Mar 26;44(6):694-708.e7. doi: 10.1016/j.devcel.2018.02.001. Epub 2018 Mar 1.

7.

Extracellular oxidation in cystic fibrosis airway epithelium causes enhanced EGFR/ADAM17 activity.

Stolarczyk M, Veit G, Schnúr A, Veltman M, Lukacs GL, Scholte BJ.

Am J Physiol Lung Cell Mol Physiol. 2018 Apr 1;314(4):L555-L568. doi: 10.1152/ajplung.00458.2017. Epub 2017 Dec 14.

8.

Mutation-specific downregulation of CFTR2 variants by gating potentiators.

Avramescu RG, Kai Y, Xu H, Bidaud-Meynard A, Schnúr A, Frenkiel S, Matouk E, Veit G, Lukacs GL.

Hum Mol Genet. 2017 Dec 15;26(24):4873-4885. doi: 10.1093/hmg/ddx367.

9.

Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell.

Bagdany M, Veit G, Fukuda R, Avramescu RG, Okiyoneda T, Baaklini I, Singh J, Sovak G, Xu H, Apaja PM, Sattin S, Beitel LK, Roldan A, Colombo G, Balch W, Young JC, Lukacs GL.

Nat Commun. 2017 Aug 30;8(1):398. doi: 10.1038/s41467-017-00444-4.

10.

Epithelial Anion Transport as Modulator of Chemokine Signaling.

Schnúr A, Hegyi P, Rousseau S, Lukacs GL, Veit G.

Mediators Inflamm. 2016;2016:7596531. doi: 10.1155/2016/7596531. Epub 2016 Jun 12. Review.

11.

Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect.

Veit G, Oliver K, Apaja PM, Perdomo D, Bidaud-Meynard A, Lin ST, Guo J, Icyuz M, Sorscher EJ, Hartman JL IV, Lukacs GL.

PLoS Biol. 2016 May 11;14(5):e1002462. doi: 10.1371/journal.pbio.1002462. eCollection 2016 May. Erratum in: PLoS Biol. 2016 Nov 2;14 (11):e1002574.

12.

From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations.

Veit G, Avramescu RG, Chiang AN, Houck SA, Cai Z, Peters KW, Hong JS, Pollard HB, Guggino WB, Balch WE, Skach WR, Cutting GR, Frizzell RA, Sheppard DN, Cyr DM, Sorscher EJ, Brodsky JL, Lukacs GL.

Mol Biol Cell. 2016 Feb 1;27(3):424-33. doi: 10.1091/mbc.E14-04-0935.

13.

Potentiators of Defective ΔF508-CFTR Gating that Do Not Interfere with Corrector Action.

Phuan PW, Veit G, Tan JA, Finkbeiner WE, Lukacs GL, Verkman AS.

Mol Pharmacol. 2015 Oct;88(4):791-9. doi: 10.1124/mol.115.099689. Epub 2015 Aug 5.

14.

Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression.

Veit G, Avramescu RG, Perdomo D, Phuan PW, Bagdany M, Apaja PM, Borot F, Szollosi D, Wu YS, Finkbeiner WE, Hegedus T, Verkman AS, Lukacs GL.

Sci Transl Med. 2014 Jul 23;6(246):246ra97. doi: 10.1126/scitranslmed.3008889.

15.

Synergy-based small-molecule screen using a human lung epithelial cell line yields ΔF508-CFTR correctors that augment VX-809 maximal efficacy.

Phuan PW, Veit G, Tan J, Roldan A, Finkbeiner WE, Lukacs GL, Verkman AS.

Mol Pharmacol. 2014 Jul;86(1):42-51. doi: 10.1124/mol.114.092478. Epub 2014 Apr 15.

16.

Collagen XXII binds to collagen-binding integrins via the novel motifs GLQGER and GFKGER.

Zwolanek D, Veit G, Eble JA, Gullberg D, Ruggiero F, Heino J, Meier M, Stetefeld J, Koch M.

Biochem J. 2014 Apr 1;459(1):217-27. doi: 10.1042/BJ20130642.

PMID:
24428702
17.

Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and mice.

Zou Y, Zwolanek D, Izu Y, Gandhy S, Schreiber G, Brockmann K, Devoto M, Tian Z, Hu Y, Veit G, Meier M, Stetefeld J, Hicks D, Straub V, Voermans NC, Birk DE, Barton ER, Koch M, Bönnemann CG.

Hum Mol Genet. 2014 May 1;23(9):2339-52. doi: 10.1093/hmg/ddt627. Epub 2013 Dec 11.

18.

Mechanism-based corrector combination restores ΔF508-CFTR folding and function.

Okiyoneda T, Veit G, Dekkers JF, Bagdany M, Soya N, Xu H, Roldan A, Verkman AS, Kurth M, Simon A, Hegedus T, Beekman JM, Lukacs GL.

Nat Chem Biol. 2013 Jul;9(7):444-54. doi: 10.1038/nchembio.1253. Epub 2013 May 12.

19.

Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia.

Veit G, Bossard F, Goepp J, Verkman AS, Galietta LJ, Hanrahan JW, Lukacs GL.

Mol Biol Cell. 2012 Nov;23(21):4188-202. doi: 10.1091/mbc.E12-06-0424. Epub 2012 Sep 12.

20.

Treatment of herpes labialis: comparison of two OTC drugs and untreated controls.

McCarthy JP, Browning WD, Teerlink C, Veit G.

J Esthet Restor Dent. 2012 Apr;24(2):103-9. doi: 10.1111/j.1708-8240.2011.00417.x. Epub 2011 Apr 27.

21.

Type XII collagen regulates osteoblast polarity and communication during bone formation.

Izu Y, Sun M, Zwolanek D, Veit G, Williams V, Cha B, Jepsen KJ, Koch M, Birk DE.

J Cell Biol. 2011 Jun 13;193(6):1115-30. doi: 10.1083/jcb.201010010.

22.

Collagen XXIII, novel ligand for integrin alpha2beta1 in the epidermis.

Veit G, Zwolanek D, Eckes B, Niland S, Käpylä J, Zweers MC, Ishada-Yamamoto A, Krieg T, Heino J, Eble JA, Koch M.

J Biol Chem. 2011 Aug 5;286(31):27804-13. doi: 10.1074/jbc.M111.220046. Epub 2011 Jun 7.

23.

Type XIV Collagen Regulates Fibrillogenesis: PREMATURE COLLAGEN FIBRIL GROWTH AND TISSUE DYSFUNCTION IN NULL MICE.

Ansorge HL, Meng X, Zhang G, Veit G, Sun M, Klement JF, Beason DP, Soslowsky LJ, Koch M, Birk DE.

J Biol Chem. 2009 Mar 27;284(13):8427-38. doi: 10.1074/jbc.M805582200. Epub 2009 Jan 9.

24.

Zebrafish collagen XII is present in embryonic connective tissue sheaths (fascia) and basement membranes.

Bader HL, Keene DR, Charvet B, Veit G, Driever W, Koch M, Ruggiero F.

Matrix Biol. 2009 Jan;28(1):32-43. doi: 10.1016/j.matbio.2008.09.580. Epub 2008 Oct 6.

PMID:
18983916
25.

Analysis of obstetric complications and uterine connective tissue in tenascin-X-deficient humans and mice.

Egging DF, van Vlijmen-Willems I, Choi J, Peeters AC, van Rens D, Veit G, Koch M, Davis EC, Schalkwijk J.

Cell Tissue Res. 2008 Jun;332(3):523-32. doi: 10.1007/s00441-008-0591-y. Epub 2008 Mar 12.

26.

Shedding of collagen XXIII is mediated by furin and depends on the plasma membrane microenvironment.

Veit G, Zimina EP, Franzke CW, Kutsch S, Siebolds U, Gordon MK, Bruckner-Tuderman L, Koch M.

J Biol Chem. 2007 Sep 14;282(37):27424-35. Epub 2007 Jul 11.

27.

The cysteine-rich domain of snake venom metalloproteinases is a ligand for von Willebrand factor A domains: role in substrate targeting.

Serrano SM, Kim J, Wang D, Dragulev B, Shannon JD, Mann HH, Veit G, Wagener R, Koch M, Fox JW.

J Biol Chem. 2006 Dec 29;281(52):39746-56. Epub 2006 Oct 13.

28.

Collagen XII interacts with avian tenascin-X through its NC3 domain.

Veit G, Hansen U, Keene DR, Bruckner P, Chiquet-Ehrismann R, Chiquet M, Koch M.

J Biol Chem. 2006 Sep 15;281(37):27461-70. Epub 2006 Jul 21.

29.

Expression of type XXIII collagen mRNA and protein.

Koch M, Veit G, Stricker S, Bhatt P, Kutsch S, Zhou P, Reinders E, Hahn RA, Song R, Burgeson RE, Gerecke DR, Mundlos S, Gordon MK.

J Biol Chem. 2006 Jul 28;281(30):21546-57. Epub 2006 May 25.

30.

Collagen XXVIII, a novel von Willebrand factor A domain-containing protein with many imperfections in the collagenous domain.

Veit G, Kobbe B, Keene DR, Paulsson M, Koch M, Wagener R.

J Biol Chem. 2006 Feb 10;281(6):3494-504. Epub 2005 Dec 5.

31.

Efficacy of sufentanil addition to ropivacaine epidural anaesthesia for Caesarean section.

Bachmann-Mennenga B, Veit G, Steinicke B, Biscoping J, Heesen M.

Acta Anaesthesiol Scand. 2005 Apr;49(4):532-7.

PMID:
15777302
32.

Epidural ropivacaine 1% with and without sufentanil addition for Caesarean section.

Bachmann-Mennenga B, Veit G, Biscoping J, Steinicke B, Heesen M.

Acta Anaesthesiol Scand. 2005 Apr;49(4):525-31.

PMID:
15777301
33.

Influence of basic heart rate and sex on heart rate turbulence in healthy subjects.

Schwab JO, Eichner G, Veit G, Schmitt H, Lewalter T, Lüderitz B.

Pacing Clin Electrophysiol. 2004 Dec;27(12):1625-31.

PMID:
15613125
34.

[Anesthesia techniques for cesarean section--catheter-peridural anesthesia].

Bachmann-Mennenga B, Veit G.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2001 Jan;36(1):53-7. Review. German. No abstract available.

PMID:
11227313
35.

Supplemental Content

Support Center